Article
Tacrolimus rescues endothelial ALK1 loss-of-function signaling and improves HHT vascular pathology
2017-05-13
Abstract excerpt
Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because HHT is caused by loss-of-function mutations in BMP9-ALK1-Smad1/5/8 signaling, interventions aimed at activating this pathway are of therapeutic value. By screening FDA-approved drug libraries, we identified tacrolimus (FK-506) as a p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a8b14e6f-a914-5911-8aca-934bc161a61a
- DOI
- 10.1101/137737
